Please use this identifier to cite or link to this item:
Title: Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma
Authors: Davison, Glenda Mary 
Keywords: Dendritic cells;immune system;tumour surveillance;peripheral blood stem cell;leukaemia
Issue Date: 2010
Publisher: Elsevier
Source: Davison, G. M. 2010. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma. Transfusion and Apheresis Science, 42(2): 189–192. []
Journal: Transfusion and Apheresis Science 
Abstract: The immune system has the ability to control and destroy malignant calls. This has been demonstrated by the graft versus leukaemia effect and the use of donor lymphocyte infu- sions in peripheral blood stem cell transplantation. Dendritic cells are potent antigen pre- senting cells and become activated after phagocytosing and processing antigen. During this process they up-regulate MHC, co-stimulatory and adhesion molecules and have the ability to stimulate naïve T-cells. Recent evidence has shown that dendritic cells can be loaded with tumour specific antigens and can be used to generate specific anti-tumour T-cell responses. Initial clinical studies using this technology have been promising and suggest that dendritic cells and T-lymphocytes can be utilised in developing therapies which target specific malignant clones.
ISSN: 1473-0502
Appears in Collections:HWSci - Journal Articles (DHET subsidised)

Files in This Item:
File Description SizeFormat 
Dendritic cells, T-cells.pdf190.59 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Feb 9, 2021


checked on Feb 9, 2021

Google ScholarTM



Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.